Andrew H Ford1, Osvaldo P Almeida2. 1. Western Australian Centre for Health and Ageing, Medical School (M577), University of Western Australia, 35 Stirling Highway, Perth, WA, 6009, Australia. andrew.ford@uwa.edu.au. 2. Western Australian Centre for Health and Ageing, Medical School (M577), University of Western Australia, 35 Stirling Highway, Perth, WA, 6009, Australia.
Abstract
BACKGROUND: Vitamin B deficiency and elevated total plasma homocysteine have been associated with cognitive impairment and dementia in later life, although it is unknown if treatment with these vitamins improves cognitive outcomes. OBJECTIVES: The objectives of this study were to examine the efficacy of treatment with vitamin B12, vitamin B6, or folic acid in slowing cognitive decline amongst older adults with and without cognitive impairment. METHODS: We summarized findings from previous systematic reviews of clinical trials and performed a new systematic review and meta-analysis of 31 English-language, randomized placebo-controlled trials of B-vitamin supplementation of individuals with and without existing cognitive impairment. RESULTS: Previous reviews have generally reported no effect of B vitamins on cognitive function in older adults with or without cognitive impairment at study entry, although these vitamins effectively lowered total plasma homocysteine levels in participants. Ten randomized placebo-controlled trials of 1925 participants with pre-existing cognitive impairment and 21 trials of 15,104 participants without cognitive impairment have been completed to date but these generally confirmed findings from previous reviews with the exception of two trials that showed a modest but clinically uncertain benefit for vitamins in people with elevated plasma homocysteine. B-vitamin supplementation did not show an improvement in Mini-Mental State Examination scores for individuals with (mean difference 0.16, 95% confidence interval - 0.18 to 0.51) and without (mean difference 0.04, 95% confidence interval - 0.10 to 0.18) cognitive impairment compared to placebo. CONCLUSIONS: Raised total plasma homocysteine is associated with an increased risk of cognitive impairment and dementia, although available evidence from randomized controlled trials shows no obvious cognitive benefit of lowering homocysteine using B vitamins. Existing trials vary greatly in the type of supplementation, population sampled, study quality, and duration of treatment, thereby making it difficult to draw firm conclusions from existing data. Findings should therefore be viewed in the context of the limitations of the available data and the lack of evidence of effect should not necessarily be interpreted as evidence of no effect.
BACKGROUND: Vitamin B deficiency and elevated total plasma homocysteine have been associated with cognitive impairment and dementia in later life, although it is unknown if treatment with these vitamins improves cognitive outcomes. OBJECTIVES: The objectives of this study were to examine the efficacy of treatment with vitamin B12, vitamin B6, or folic acid in slowing cognitive decline amongst older adults with and without cognitive impairment. METHODS: We summarized findings from previous systematic reviews of clinical trials and performed a new systematic review and meta-analysis of 31 English-language, randomized placebo-controlled trials of B-vitamin supplementation of individuals with and without existing cognitive impairment. RESULTS: Previous reviews have generally reported no effect of B vitamins on cognitive function in older adults with or without cognitive impairment at study entry, although these vitamins effectively lowered total plasma homocysteine levels in participants. Ten randomized placebo-controlled trials of 1925 participants with pre-existing cognitive impairment and 21 trials of 15,104 participants without cognitive impairment have been completed to date but these generally confirmed findings from previous reviews with the exception of two trials that showed a modest but clinically uncertain benefit for vitamins in people with elevated plasma homocysteine. B-vitamin supplementation did not show an improvement in Mini-Mental State Examination scores for individuals with (mean difference 0.16, 95% confidence interval - 0.18 to 0.51) and without (mean difference 0.04, 95% confidence interval - 0.10 to 0.18) cognitive impairment compared to placebo. CONCLUSIONS: Raised total plasma homocysteine is associated with an increased risk of cognitive impairment and dementia, although available evidence from randomized controlled trials shows no obvious cognitive benefit of lowering homocysteine using B vitamins. Existing trials vary greatly in the type of supplementation, population sampled, study quality, and duration of treatment, thereby making it difficult to draw firm conclusions from existing data. Findings should therefore be viewed in the context of the limitations of the available data and the lack of evidence of effect should not necessarily be interpreted as evidence of no effect.
Authors: Simone J Eussen; Lisette C de Groot; Liesbeth W Joosten; Rubia J Bloo; Robert Clarke; Per M Ueland; Jörn Schneede; Henk J Blom; Willibrord H Hoefnagels; Wija A van Staveren Journal: Am J Clin Nutr Date: 2006-08 Impact factor: 7.045
Authors: Jane Durga; Martin P J van Boxtel; Evert G Schouten; Frans J Kok; Jelle Jolles; Martijn B Katan; Petra Verhoef Journal: Lancet Date: 2007-01-20 Impact factor: 79.321
Authors: Timothy Kwok; Jenny Lee; Ronald C Ma; Samuel Y Wong; Kenny Kung; Augustine Lam; C S Ho; Vivian Lee; John Harrison; Linda Lam Journal: Clin Nutr Date: 2016-10-27 Impact factor: 7.324
Authors: A David Smith; Helga Refsum; Teodoro Bottiglieri; Michael Fenech; Babak Hooshmand; Andrew McCaddon; Joshua W Miller; Irwin H Rosenberg; Rima Obeid Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: John E Lewis; Jillian Poles; Delaney P Shaw; Elisa Karhu; Sher Ali Khan; Annabel E Lyons; Susana Barreiro Sacco; H Reginald McDaniel Journal: J Clin Transl Res Date: 2021-08-04
Authors: Deirdre M A O'Connor; Siobhan Scarlett; Céline De Looze; Aisling M O'Halloran; Eamon Laird; Anne M Molloy; Robert Clarke; Christine A McGarrigle; Rose Anne Kenny Journal: Eur J Clin Nutr Date: 2022-01-13 Impact factor: 4.884
Authors: Cheng Chen; Eric A Whitsel; Mark A Espeland; Linda Snetselaar; Kathleen M Hayden; Archana P Lamichhane; Marc L Serre; William Vizuete; Joel D Kaufman; Xinhui Wang; Helena C Chui; Mary E D'Alton; Jiu-Chiuan Chen; Ka Kahe Journal: Alzheimers Dement Date: 2022-02-01 Impact factor: 16.655
Authors: Stefan Markun; Isaac Gravestock; Levy Jäger; Thomas Rosemann; Giuseppe Pichierri; Jakob M Burgstaller Journal: Nutrients Date: 2021-03-12 Impact factor: 5.717